Publications
View complete list of Flythe publications on PubMed.
Select New
Mehrotra R, Davison SN, Farrington K, Flythe JE, Foo M, Madero M, Morton RL, Tsukamoto Y, Unruh ML, Cheung M, Jadoul M, Winkelmayer WC, Brown EA; Conference Participants. Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023 Sep;104(3):441-454. doi: 10.1016/j.kint.2023.05.019. Epub 2023 Jun 7. PMID: 37290600.
Barraclough KA, Berman-Parks B, Jha V, Piccoli GB, Sigant C, Talbot B, Tarrass F, Cheung M, King JM, Grams ME, Jadoul M, Flythe JE on behalf of the Conference Participants. Green Dialysis: Environmentally sustainable care, growth, and innovation: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2026 Feb 17:S0085-2538(26)00079-7. doi: 10.1016/j.kint.2026.01.015; PMID:41713645.
Cervantes L, Juarez-Colunga E, Powe NR, Flythe JE, Steiner JF, Cukor D, Hasnain-Wynia R, Furgeson S, Golestaneh L, Camacho C, McBeth L, Beaty BL, Shi J, Bacon E, Chonchol M. Community health worker support for Hispanic and Latino individuals receiving hemodialysis: The Navigate-Kidney randomized clinical trial. JAMA Intern Med Published online: JAMA Intern Med. 2026 Jan 1;186(1):56-66. doi: 10.1001/jamainternmed.2025.5305; PMCID: PMC12595546.
Flythe JE, Picataggio CB, Bernardo L, Dalrymple LS, Kossmann RJ, DeWalt DA, Hanson LC, Wang V, Unruh ML, Hsu JY, Dember LM. Design and rationale of the SMaRRT–HD study: A pragmatic randomized trial of symptom monitoring for individuals receiving maintenance hemodialysis. Contemp Clin Trials. 2025 Oct:157:108058. doi: 10.1016/j.cct.2025.108058. PMID: 40889553
Nash RP**, Ismail S, Gaynes BN, Flythe JE. Comparative safety of haloperidol vs. chlorpromazine among people receiving maintenance hemodialysis. J of Psych Research. 2025 Aug:188:235-242. doi: 10.1016/j.jpsychires.2025.05.065. PMID: 40451117; PMCID: PMC12204734.
Haddad S**, Kittner N, Flythe JE. Thinking globally, acting locally: water use in a hospital hemodialysis unit. Kidney360. 2024 Nov 1:5(11):1747-1749. doi: 10.34067/KID.0000000590. PMID: 39316440.
Wang V, Wang L, Assimon MM, Pun PH, Winkelmayer WC, Flythe JE. Prescription and dispensation patterns of QT-prolonging medications among individuals with kidney failure receiving hemodialysis. JAMA Netw Open. 2024 Apr 1;7(4):e248732. doi: 10.1001/jamanetworkopen.2024.8732. PMID: 38687480.
Ismail S**, Funk MJ, Flythe JE. Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis. J Am Soc Nephrol. 2024 Jun 1;35(6):761-771. doi: 10.1681/ASN.0000000000000336. Epub 2024 Feb 27. PMID: 38409683; PMCID: PMC11164116.
Nash RP**, Wang L, Gaynes BN, Flythe JE. Atypical antipsychotics and the risk of sudden cardiac death among individuals receiving maintenance hemodialysis. Gen Hosp Psych. 2023 Nov-Dec;85. doi: 10.1016/j.genhosppsych.2023.10.016
Bansal N. Artinian NT, Bakris G, Chant T, Cohen J, Flythe J, Lea J, Vongpatanasin W, Chertow GM. Hypertension in patients treated with maintenance hemodialysis: Current evidence and future opportunities: A scientific statement from the American Heart Association. Hypertension 2023 Jun;80(6):e112-e122. doi: 10.1161/HYP.0000000000000230. PMID: 37092336
Pun PH, Assimon MM, Wang L, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE. QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance Hemodialysis. Kidney Med. 2023 Feb 15;5(5):100618. doi: 10.1016/j.xkme.2023.100618. eCollection 2023 May.
Flythe JE, Forfang D, Harris RC, Wood D, Hurst FP, Tarver ME; Building Capacity to Incorporate Patient Preferences into the Development of Innovative Alternatives to Renal Replacement Therapy team*. Risk Tolerance in the Setting of Wearable Dialysis Devices: A Patient Preference Study Using the Threshold Technique. J Am Soc Nephrol. 2023 Mar 15. doi: 10.1681/ASN.0000000000000120. Online ahead of print.
Flythe JE. Integrating PROMs in Routine Dialysis Care: The Devil Is in the (Implementation) Details. Clin J Am Soc Nephrol. 2022 Nov;17(11):1580-1582. doi: 10.2215/CJN.10840922. Epub 2022 Oct 25.PMID: 36283761.
Flythe JE, Assimon MM, Tugman MJ, Narendra JH, Singh SK, Jin W, Li Q, Bansal N, Hostetter TH, Dember LM. Efficacy, Safety, and Tolerability of Oral Furosemide Among Patients Receiving Hemodialysis: A Pilot Study. Kidney Int Rep. 2022 Jul 12;7(10):2186-2195. doi: 10.1016/j.ekir.2022.07.003. PMID: 36217511; PMCID: PMC9546731.
Flythe JE, Assimon MM. Diuretic Use Among Patients Receiving Hemodialysis in the United States. Kidney Med. 2022 Jul 22;4(9):100520. doi: 10.1016/j.xkme.2022.100520. PMID: 36147200; PMCID: PMC9485589.
Flythe JE, Forfang D, Gedney N, White DM, Wilkie C, Cavanaugh KL, Harris RC, Unruh M, Squillaci G, West M, Mansfield C, Soloe CS, Treiman K, Wood D, Hurst FP, Neuland CY, Saha A, Sheldon M, Tarver ME. Development of a Patient Preference Survey for Wearable Kidney Replacement Therapy Devices. Kidney360. 2022 May 5;3(7):1197-1209. doi: 10.34067/KID.0001862022. PMID: 35919522; PMCID: PMC9337889.
Klein KR, Pate V, Assimon MM, Stürmer T, Buse JB, Flythe JE. Antihyperglycemic Medication Use Among U.S. Adults With Hemodialysis-Dependent Kidney Disease and Comorbid Diabetes. Diabetes Care. 2022 Sep 1;45(9):126-128. doi: 10.2337/dc22-0659. PMID: 35861431; PMCID: PMC9472491.
Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE. The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study. Nephrol Dial Transplant. 2022 Oct 19;37(11):2241-2252. doi: 10.1093/ndt/gfac214. PMID: 35793567.
Assimon MM, Pun PH, Wang L, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE. Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure. Kidney Int. 2022 Oct;102(4):894-903. doi: 10.1016/j.kint.2022.05.024. Epub 2022 Jun 23. PMID: 35752324; PMCID: PMC9509424.
Assimon MM, Pun PH, Al-Khatib SM, Brookhart MA, Gaynes BN, Winkelmayer WC, Flythe JE. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):670-679. doi: 10.1002/pds.5428. Epub 2022 Mar 24. PMID: 35285107; PMCID: PMC9064943.
Assimon MM, Pun PH, Wang LC, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. 2022 Jan 1;7(1):75-83. doi: 10.1001/jamacardio.2021.4234. PMID: 34668928; PMCID: PMC8756330.
Flythe JE, West M. Using Patient Preference Information to Inform Regulatory Decision Making: An Opportunity to Spur Patient-Centered Innovation in Kidney Replacement Therapy Devices. Clin J Am Soc Nephrol. 2021 Apr 7;16(4):642-644. doi: 10.2215/CJN.11930720. Epub 2021 Mar 3. PMID: 33658178; PMCID: PMC8092071.
Flythe JE, Narendra JH, Yule C, Manivannan S, Murphy S, Lee SD, Strigo TS, Peskoe S, Pendergast JF, Boulware LE, Green JA. Targeting Patient and Health System Barriers To Improve Rates of Hemodialysis Initiation with an Arteriovenous Access. Kidney360. 2021 Feb 26;2(4):708-720. doi: 10.34067/KID.0007812020. PMID: 35373037; PMCID: PMC8791324.
Dorough A, Forfang D, Mold JW, Kshirsagar AV, DeWalt DA, Flythe JE. A Person-Centered Interdisciplinary Plan-of-Care Program for Dialysis: Implementation and Preliminary Testing. Kidney Med. 2021 Feb 6;3(2):193-205.e1. doi: 10.1016/j.xkme.2020.11.010. PMID: 33851115; PMCID: PMC8039412.